Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Viking Thera
(NQ:
VKTX
)
65.07
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Viking Thera
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
VKTX Stock Earnings: Viking Therapeutics Beats EPS for Q1 2024
April 24, 2024
VKTX stock results show that Viking Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Viking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEO
April 24, 2024
Viking Therapeutics reports quarterly losses of 26 cents per share which beat the analyst consensus estimate of losses of 28 cents by 7.14%. Research and development expenses were $24.1 million for the...
Via
Benzinga
3 Biotech Stocks With Skyrocketing Potential: April 2024
April 24, 2024
These three biotech stocks, with robust fundamentals and long-term prospects represent the sector’s finest at this time.
Via
InvestorPlace
3 Red-Hot Biotech Rockets Blasting Off in 2024
April 24, 2024
The economy is looking very strong and the biotech industry even more so, thus consider these top three stocks for strong profits.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 24, 2024
Good news could be just around the corner for two drugmakers not named Novo Nordisk.
Via
The Motley Fool
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
These two pharma stocks have followed distinct paths of late. Which is the better investment?
Via
The Motley Fool
Looking At Viking Therapeutics's Recent Unusual Options Activity
April 22, 2024
Via
Benzinga
Market Whales and Their Recent Bets on VKTX Options
April 18, 2024
Via
Benzinga
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
April 15, 2024
Via
Benzinga
1 No-Brainer Vanguard Fund to Buy Right Now
April 23, 2024
This Vanguard growth fund is home to some of the world's most innovative companies.
Via
The Motley Fool
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
April 23, 2024
These stocks to buy are set to surpass analyst expectations, with exciting product and service developments sparking unforeseen growth.
Via
InvestorPlace
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
April 16, 2024
These three biotech stocks are leading the sector higher on upbeat news but is this as good as it gets or do they have more gas in the tank?
Via
InvestorPlace
Viking Therapeutics: Strong Results In Obesity
April 13, 2024
With a potential best in class drug for oral and injectable use, Viking Therapeutics has to be on many Big Pharma/Bio acquisition wish lists, as the company represents a very scarce asset in the $100...
Via
Talk Markets
3 Magnificent Stocks That Could Double or More by 2030
April 13, 2024
There's no guarantee these stocks will double by 2030, but their growth prospects look great.
Via
The Motley Fool
Viking Therapeutics's Options: A Look at What the Big Money is Thinking
April 09, 2024
Via
Benzinga
Is it Too Late to Buy Viking Therapeutics Stock?
April 06, 2024
Viking Therapeutics stock is on fire following a successful phase 2 trial for its obesity care candidate.
Via
The Motley Fool
Viking Therapeutics Just Announced More Positive Results: Time to Buy?
April 04, 2024
The drugmaker isn't losing momentum.
Via
The Motley Fool
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
April 12, 2024
For investors looking for a way to play weight-loss stocks in this current backdrop, here are three top options to consider right now.
Via
InvestorPlace
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
April 11, 2024
Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments.
Via
InvestorPlace
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
April 09, 2024
These rising drugmakers have serious arguments in their favor.
Via
The Motley Fool
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.
April 09, 2024
Viking Therapeutics has garnered a lot of attention following a successful clinical trial for its obesity care drug. But another development-stage biotech may have a superior candidate.
Via
The Motley Fool
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.
April 08, 2024
Shares of the clinical-stage biotech have skyrocketed on recent good news.
Via
The Motley Fool
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
April 05, 2024
These businesses should see good times ahead.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
Via
Benzinga
1 Brand-New (Good) Reason to Buy Viking Therapeutics Stock Now
April 04, 2024
Its long-term growth potential looks like it's improving, again.
Via
The Motley Fool
2 Potentially Explosive Stocks to Buy in April
April 04, 2024
These two healthcare stocks should have plenty of room to run.
Via
The Motley Fool
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
April 04, 2024
Viking shares have soared recently on optimism about its program.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 03, 2024
Via
Benzinga
5 Healthcare Stocks to Buy for 2024
April 02, 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts
April 02, 2024
With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.